Your browser doesn't support javascript.
loading
Trimetazidine mitigates high glucose-induced retinal endothelial dysfunction by inhibiting PI3K/Akt/mTOR pathway-mediated autophagy.
Yang, Qingsong; Li, Sizhen; Zhou, Zixiu; Yang, Xiaodong; Liu, Yating; Hao, Kuanxiao; Fu, Min.
Afiliação
  • Yang Q; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Li S; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Zhou Z; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Yang X; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Liu Y; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Hao K; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
  • Fu M; Nanjing Tongren Eye Center, Nanjing Tongren Hospital, School of Medicine Southeast University, Nanjing, P.R. China.
Bioengineered ; 13(3): 7515-7527, 2022 03.
Article em En | MEDLINE | ID: mdl-35259050
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trimetazidina / Fosfatidilinositol 3-Quinases Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trimetazidina / Fosfatidilinositol 3-Quinases Limite: Humans Idioma: En Revista: Bioengineered Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos